TAO Synergies TAOX
NASDAQ TAOX
$4.13 +0.12 (+2.99%)
As of: Sep 9, 2026 · 2:42 PM EDT

TAO Synergies (TAOX) Preferred Stock Liabilities (2020 - 2026)

TAO Synergies' (TAOX) quarterly Preferred Stock Liabilities came in at $3.9 million in Q2 2026, up 763.35% on a YoY basis from $446942.0 in Q2 2025, and up 74.52% quarter-over-quarter from $2.2 million in Q1 2026.

Analysis

TAO Synergies (TAOX) Preferred Stock Liabilities (2020 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Preferred Stock Liabilities for 7 consecutive years, with $3.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Preferred Stock Liabilities rose 763.35% year-over-year to $3.9 million; the trailing twelve-month figure through Jun 2026 stood at $3.9 million (up 763.35% YoY), and the FY2025 full-year result was $507927.0, down 44.36% from the prior year.
  • Preferred Stock Liabilities advanced to $3.9 million in Q2 2026 per TAOX's latest filing, from $2.2 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $31.5 million in Q1 2023 and bottomed at $314473.0 in Q3 2024.
  • Historically, Preferred Stock Liabilities has averaged $5.1 million across 5 years, with a median of $1.3 million in 2025.
  • The sharpest annual moves came in 2024 and 2026: Preferred Stock Liabilities tumbled 97.38% in 2024, then surged 763.35% in 2026.
  • Over 5 years, Preferred Stock Liabilities stood at $2.7 million in 2022, then tumbled by 54.55% to $1.2 million in 2023, then fell by 26.2% to $912830.0 in 2024, then sank by 44.36% to $507927.0 in 2025, then jumped by 659.69% to $3.9 million in 2026.
  • According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $3.9 million, $2.2 million, and $507927.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Amgen 210.97 Bn 196.98 Bn 7.24 Bn -
2 Gilead Sciences 180.98 Bn 177.80 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.09 Bn 124.24 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.56 Bn 74.57 Bn 3.93 Bn -
5 Argenx Se 61.71 Bn 56.53 Bn 1.37 Bn -
6 Moderna 54.60 Bn 49.46 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.02 Bn 30.71 Bn 992.69 Mn -
8 Biogen 31.25 Bn 29.97 Bn 1.96 Bn -
9 Roivant Sciences 29.76 Bn 29.76 Bn 1.16 Mn -
10 TAO Synergies 30.86 Mn 30.86 Mn - 3.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.86 Mn
Mar 31, 2026 2.21 Mn
Dec 31, 2025 507,927.00
Sep 30, 2025 603,797.00
Jun 30, 2025 446,942.00
Mar 31, 2025 1.28 Mn
Dec 31, 2024 912,830.00
Sep 30, 2024 314,473.00
Mar 31, 2024 823,555.00
Dec 31, 2023 1.24 Mn
Sep 30, 2023 1.69 Mn
Jun 30, 2023 2.08 Mn
Mar 31, 2023 31.46 Mn
Dec 31, 2022 2.72 Mn
Sep 30, 2022 26.67 Mn
Dec 31, 2021 33.53 Mn
Dec 31, 2020 5.14 Mn